RCUS - Arcus Biosciences, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue8,3531,413-
Cost of Revenue49,64647,21814,247
Gross Profit-41,293-45,805-14,247
Operating Expenses
Research Development---
Selling General and Administrative13,5667,6363,935
Non Recurring---
Total Operating Expenses63,21254,85418,182
Operating Income or Loss-54,859-53,441-18,182
Income from Continuing Operations
Total Other Income/Expenses Net5,265359212
Earnings Before Interest and Taxes-54,859-53,441-18,182
Interest Expense---
Income Before Tax-49,594-53,082-17,970
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-49,594-53,082-17,970
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-49,594-53,082-17,970
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-49,594-53,082-17,970